Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells

Autor: Chiesa S. 1, 2, 3, Morbelli S. 4, Morando S.1, Massollo M. 4, Marini C. 5, Bertoni A. 1, Frassoni F. 6, Tabera Bartolomé S. 7, 8, Sambucetid G. 4, Traggiai E. 3, 9, Uccelli A. 1

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America 108 (2011): 17384–17389.
info:cnr-pdr/source/autori:Chiesa S. 1,2,3, Morbelli S. 4, Morando S.1,2, Massollo M. 4, Marini C. 5, Bertoni A. 1,2, Frassoni F. 6, Tabera Bartolomé S. 7,8, Sambucetid G. 4, Traggiai E. 3,9, Uccelli A. 1,2,10/titolo:Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells/doi:/rivista:Proceedings of the National Academy of Sciences of the United States of America/anno:2011/pagina_da:17384/pagina_a:17389/intervallo_pagine:17384–17389/volume:108

Dendritic cells (DC) are highly specialized antigen-presenting cells characterized by the ability to prime T-cell responses. Mesenchymal stem cells (MSC) are adult stromal progenitor cells displaying immunomodulatory activities including inhibition o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::ec567496641744bb9c7aec52e2a1ac76
https://publications.cnr.it/doc/10534